organization · Reporting owner
BlueLine Partners, L.L.C.
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CYANOTECH CORPCYAN · Entity 8431 | 10% owner | November 07, 2018 | November 09, 2018 |
| IRIDEX CORPIRIX · Entity 7882 | 10% owner | November 21, 2017 | November 22, 2017 |
| InfuSystem Holdings, IncINFU · Entity 6163 | 10% owner | December 07, 2020 | December 09, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CYANOTECH CORP
Report date November 07, 2018 · Filed November 09, 2018
Jointly reported with Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 850,116 |
Reported balance
After 2018-11-07 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2018-11-07 · Other · Acquired 100,506 · Balance 850,116 F1: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity. F2: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity.
F2: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock.
IRIDEX CORP
Report date November 21, 2017 · Filed November 22, 2017
Jointly reported with BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, LP, BlueLine Partners II, LLC, BlueLine Catalyst Fund IX, L.P.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,138,862 |
Reported balance
After 2017-11-21 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2017-11-21 · Other · Disposed 267,631 · Balance 1,138,862 F1: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. F2: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.
F2: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement.
InfuSystem Holdings, Inc
Report date December 07, 2020 · Filed December 09, 2020
Jointly reported with BlueLine Capital Partners II, L.P., Meridian OHC LLC, Meridian TSV II, LP, TSV Investment Partners, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 493,656 |
Last balance in matching sequence
After 2020-12-09 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2020-12-07 · Sale · Disposed 2,900 · Balance 499,850 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 2 · 2020-12-08 · Sale · Disposed 4,489 · Balance 495,361 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Row 3 · 2020-12-09 · Sale · Disposed 1,705 · Balance 493,656 F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. |
Filing footnotes · ownership attribution and instrument terms
F1: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2020 Filed Dec 9, 2020 17:40 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 1,705 | $17.00 | $28,985.00 |
DisclosureSEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 3 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,656 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 08, 2020 Filed Dec 9, 2020 17:40 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 4,489 | $17.04 | $76,492.56 |
DisclosureSEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 2 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,361 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 07, 2020 Filed Dec 9, 2020 17:40 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 2,900 | $17.21 | $49,909.00 |
DisclosureSEC source: 0001096906-20-000461 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,850 F1 · ownership.direct: 1. These securities were owned by BlueLine Capital Partners II, LP. The shares were sold on behalf of the estate of a limited partner of the fund that passed during the year. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 18:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | OtherCommon Stock | 273,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-20-001474 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,750 F2 · ownership.direct: These securities were owned by Meridian TSV II, LP. On September 30, 2020, Meridian TSV II, LP. executed an in-kind distribution, without consideration, of 273,457 of the Issuer's common stock to certain of its limited partners. Read SEC document |
| September 30, 2020 Filed Oct 2, 2020 18:09 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | OtherCommon Stock | 2,009,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-20-001474 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,207 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. On September 30, 2020, Meridian OHC Partners, LP executed an in-kind distribution, without consideration, of 2,009,580 of the Issuer's common stock to certain of its limited partners. Read SEC document |
| September 29, 2020 Filed Sep 30, 2020 18:04 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 45,604 | $13.89 | $633,439.56 |
DisclosureSEC source: 0001445866-20-001428 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,183 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 28, 2020 Filed Sep 30, 2020 18:04 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 37,300 | $13.93 | $519,589.00 |
DisclosureSEC source: 0001445866-20-001428 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,785,787 F1 · ownership.direct: These securities were owned by Meridian OHC Partners, LP. The shares reported in Column 4 were sold in multiple transactions and the price reported is the weighted-average price for the day. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 18:08 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | OtherCommon Stock | 16,801 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-20-000847 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner Meridian OHC LLC · CIK 0001601538 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,339,760 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners II, LP. On June 11, 2020, BlueLine Capital Partners II, LP executed an in-kind distribution, without consideration, of 16,801 shares of the Issuer's common stock to certain of its limited partners. BlueLine Partners, LLC is the general partner of BlueLine Capital Partners II, LP, and Scott Shuda is managing director of BlueLine Partners, LLC. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. Read SEC document |
| March 31, 2020 Filed Mar 31, 2020 22:03 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | SaleCommon Stock | 169,960 | $8.37 | $1,422,531.21 |
DisclosureSEC source: 0001445866-20-000310 · primary_doc.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Footnote 1 Disclosed balance after: 3,356,561 F1 · ownership.direct: These securities are owned by Imua T Capital Investments, LLC. The price reported in Column 4 is a weighted average price. These shares reported herein were traded in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares traded at each separate price. Imua T Capital Investments, LLC is a member of the group described in Amendment No. 1 to Schedule 13D filed by Meridian OHC Partners, LP and others on August 31, 2018. Imua T Capital Investments, LLC is managed separately from the other members of such group, and the securities reported transacting herein were all of the shares held by Imua T Capital Investments, LLC. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 20:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,123 | $4.54 | $5,098.42 |
DisclosureSEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 3 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,521,517 F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 20:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,500 | $4.54 | $11,350.00 |
DisclosureSEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 2 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,520,394 F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F2 · ownership.direct: These securities are owned by Scott Shuda. Read SEC document |
| June 14, 2019 Filed Jun 17, 2019 20:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,100 | $4.43 | $4,873.00 |
DisclosureSEC source: 0001445866-19-000723 · form4.xml · nonDerivative · entry 1 Shuda Scott · CIK 0001486636 · Director · 10% owner Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,517,894 F4 · price: The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F1 · ownership.direct: These securities are owned by Meridian TSV II, LP Read SEC document |
| November 07, 2018 Filed Nov 9, 2018 13:49 UTC | CYANOTECH CORP CYAN · Entity 8431 | OtherCommon Stock | 100,506 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-18-001201 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 850,116 F1 · ownership.direct: These securities are owned by Meridian TSV II, LP. The shares were contributed to that entity by a limited partner in such entity. F2 · ownership.direct: As described in the Schedule 13D filing made on May 9, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| June 14, 2018 Filed Jun 14, 2018 18:12 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 132,020 | $3.10 | $409,262.00 |
DisclosureSEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 5 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,346,834 F3 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 14, 2018 Filed Jun 14, 2018 18:12 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,000 | $3.10 | $46,500.00 |
DisclosureSEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,214,814 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 18:12 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 10,000 | $3.15 | $31,500.00 |
DisclosureSEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,199,814 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 18:12 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 162 | $3.00 | $486.00 |
DisclosureSEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,814 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 18:12 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $3.05 | $15,250.00 |
DisclosureSEC source: 0001445866-18-000647 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189,652 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| May 22, 2018 Filed May 22, 2018 18:05 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $3.00 | $15,000.00 |
DisclosureSEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,184,652 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| May 18, 2018 Filed May 22, 2018 18:05 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 841 | $2.85 | $2,396.85 |
DisclosureSEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,179,652 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. Read SEC document |
| May 18, 2018 Filed May 22, 2018 18:05 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 944 | $2.85 | $2,690.40 |
DisclosureSEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,178,811 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| May 17, 2018 Filed May 22, 2018 18:05 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 5,000 | $2.90 | $14,500.00 |
DisclosureSEC source: 0001445866-18-000596 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,177,867 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. F3 · ownership.direct: The amount of securities beneficially owned by the Reporting Persons was incorrectly stated on the Form 4 filed on May 24, 2017 and was reflected in all subsequent reports but is being corrected with this Form 4 filing. Read SEC document |
| May 14, 2018 Filed May 14, 2018 16:57 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,055 | $2.79 | $5,733.45 |
DisclosureSEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,196,200 F2 · ownership.direct: These securities are owned by Meridian TSV II, LP. Read SEC document |
| May 14, 2018 Filed May 14, 2018 16:57 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 30,000 | $2.80 | $84,000.00 |
DisclosureSEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,194,145 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| May 10, 2018 Filed May 14, 2018 16:57 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 8,493 | $2.60 | $22,081.80 |
DisclosureSEC source: 0001445866-18-000545 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · 10% owner Meridian TSV II, LP · CIK 0001601536 · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,164,145 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| March 16, 2018 Filed Mar 16, 2018 17:29 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 20,000 | $2.40 | $48,000.00 |
DisclosureSEC source: 0001445866-18-000266 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,155,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 18:35 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 20,000 | $2.35 | $47,000.00 |
DisclosureSEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 5 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,115,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 18:35 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 24,000 | $2.30 | $55,200.00 |
DisclosureSEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 4 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,095,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| December 13, 2017 Filed Dec 14, 2017 18:35 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 4,767 | $2.30 | $10,964.10 |
DisclosureSEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,071,652 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 18:35 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 3,233 | $2.35 | $7,597.55 |
DisclosureSEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,066,885 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 18:35 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 12,000 | $2.32 | $27,840.00 |
DisclosureSEC source: 0001445866-17-001762 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,063,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. F3 · ownership.direct: As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| December 08, 2017 Filed Dec 8, 2017 17:20 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 1,800 | $2.30 | $4,140.00 |
DisclosureSEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,051,652 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 17:20 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,000 | $2.35 | $35,250.00 |
DisclosureSEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,049,852 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 06, 2017 Filed Dec 8, 2017 17:20 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 7,300 | $2.30 | $16,790.00 |
DisclosureSEC source: 0001445866-17-001749 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,034,852 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 22:53 UTC | IRIDEX CORP IRIX · Entity 7882 | OtherCommon Stock | 267,631 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-17-001714 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners III, LP · CIK 0001411986 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner BlueLine Partners II, LLC · CIK 0001411987 · 10% owner BlueLine Catalyst Fund IX, L.P. · CIK 0001460518 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,138,862 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners III, L.P. On November 21, 2017, BlueLine Capital Partners III, L.P. executed an in-kind distribution, without consideration, of 267,631 shares of the Issuer's common stock to certain of its limited partners. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. F2 · ownership.direct: As described in Amendment No. 4 to Schedule 13D ("Amendment No. 4") filed on October 25, 2007 with respect to the securities owned by BlueLine Capital Partners, L.P., BlueLine Capital Partners II, L.P., BlueLine Capital Partners III, L.P., BlueLine Catalyst Fund VIII, L.P., BlueLine Catalyst Fund IX, L.P., BlueLine Partners, L.L.C., and BlueLine Partners II, L.L.C., as of the date of Amendment No. 4, the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Entity may have been deemed to have beneficial ownership of 10% or more of the securities. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, any Reporting Person is the beneficial owner of any Common Stock covered by this statement. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 19:06 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 4,982 | $2.00 | $9,964.00 |
DisclosureSEC source: 0001445866-17-001315 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,027,552 F2 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 19:06 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,000 | $2.00 | $30,000.00 |
DisclosureSEC source: 0001445866-17-001315 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,022,570 F1 · ownership.direct: These securities are owned by Meridian TSV II, LP. Read SEC document |
| September 08, 2017 Filed Sep 8, 2017 19:53 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | OtherCommon Stock | 225,000 | $2.00 | $450,000.00 |
DisclosureSEC source: 0001445866-17-001311 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,007,570 F1 · ownership.direct: These securities are owned by Meridian TSV II, LP., and were acquired coincident to a subscription by a new limited partner to such entity. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 17:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 600 | $1.90 | $1,140.00 |
DisclosureSEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,782,570 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 30, 2017 Filed Aug 30, 2017 17:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 300 | $1.85 | $555.00 |
DisclosureSEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,781,970 F2 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 21:35 UTC | IRIDEX CORP IRIX · Entity 7882 | OtherCommon Stock | 54,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-17-001279 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner BlueLine Catalyst Fund IX, L.P. · CIK 0001460518 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners III, LP · CIK 0001411986 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner BlueLine Partners II, LLC · CIK 0001411987 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,406,493 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners, L.P. On August 28, 2017, BlueLine Capital Partners, L.P. executed an in-kind distribution, without consideration, of 54,195 shares of the Issuer's common stock to certain of its limited partners. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 17:36 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 30,000 | $1.90 | $57,000.00 |
DisclosureSEC source: 0001445866-17-001281 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,781,670 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. Read SEC document |
| August 25, 2017 Filed Aug 25, 2017 17:54 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 11,060 | $1.85 | $20,461.00 |
DisclosureSEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,751,670 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 17:54 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 155 | $1.80 | $279.00 |
DisclosureSEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,610 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 23, 2017 Filed Aug 25, 2017 17:54 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 2,166 | $1.80 | $3,898.80 |
DisclosureSEC source: 0001445866-17-001277 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,455 F1 · ownership.direct: These securities are owned by BlueLine Capital Partners II, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2017 Filed Aug 16, 2017 18:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 26,670 | $1.80 | $48,006.00 |
DisclosureSEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 3 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,738,289 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 16, 2017 Filed Aug 16, 2017 18:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,000 | $1.85 | $27,750.00 |
DisclosureSEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,711,619 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 14, 2017 Filed Aug 16, 2017 18:44 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 15,000 | $1.90 | $28,500.00 |
DisclosureSEC source: 0001445866-17-001234 · form4.xml · nonDerivative · entry 1 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,696,619 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 22, 2017 Filed Jun 23, 2017 23:25 UTC | IRIDEX CORP IRIX · Entity 7882 | OtherCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001445866-17-000922 · form4.xml · nonDerivative · entry 1 BlueLine Capital Partners, L.P. · CIK 0001338149 · 10% owner BlueLine Catalyst Fund IX, L.P. · CIK 0001460518 · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · 10% owner BlueLine Capital Partners III, LP · CIK 0001411986 · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · 10% owner BlueLine Partners II, LLC · CIK 0001411987 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,460,688 F1 · ownership.direct: These securities were owned by BlueLine Capital Partners, L.P. On June 22, 2017, BlueLine Capital Partners, L.P. executed an in-kind distribution, without consideration, of 600,000 shares of the Issuer's common stock to certain of its limited partners. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 17:29 UTC | InfuSystem Holdings, Inc INFU · Entity 6163 | PurchaseCommon Stock | 109 | $1.50 | $163.50 |
DisclosureSEC source: 0001445866-17-000838 · form4.xml · nonDerivative · entry 2 Meridian OHC Partners, LP · CIK 0001601397 · Director · 10% owner Meridian TSV II, LP · CIK 0001601536 · Director · 10% owner TSV Investment Partners, LLC · CIK 0001603326 · Director · 10% owner BlueLine Capital Partners II, L.P. · CIK 0001460781 · Director · 10% owner BlueLine Partners, L.L.C. · CIK 0001311443 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,681,619 F1 · ownership.direct: These securities are owned by Meridian OHC Partners, LP. As described in the Schedule 13D filing made on February 12, 2016 with respect to the Common Stock owned by Meridian OHC Partners, LP, Meridian TSV II, LP, TSV Investment Partners, LLC, BlueLine Capital Partners II, L.P. and BlueLine Partners, L.L.C., the Reporting Entities may have been deemed to be a "group" under Section 13(d) of the Securities Exchange Act and accordingly each Reporting Person may have been deemed to have beneficial ownership of 10% or more of the Common Stock. The price reported in Column 4 is a weighted average price. These shares reported herein were purchased in multiple transactions. The reporting persons undertake to provide to InfuSystem Holdings, Inc., any security holder of InfuSystem Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.